NHI Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2026Q1

FY2026Q2

95.63M

+11.52%

0.798

-16%

95.04M

+6.43%

0.808

+9.24%

97.40M

+7.44%

0.859

+8.77%

Estimates Revision

The market is revising Upward the revenue expectations for National Health Investors, Inc. (NHI) for FY2025, with the revenue forecasts being adjusted by 2.67% over the past three months. During the same period, the stock price has changed by 3.46%.

Revenue Estimates for FY2025

Revise Upward

+2.67%

In Past 3 Month

EPS Estimates for FY2025

Revise Downward

-0.22%

In Past 3 Month

Stock Price

Go Up

+3.46%

In Past 3 Month

5 Analyst Rating

Wall Street analysts forecast NHI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NHI is 87.50 USD with a low forecast of 80.00 USD and a high forecast of 90.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

4 Buy

1 Hold

0 Sell

Strong Buy

Current: 0.000

Low

80.00

Averages

87.50

High

90.00

Current: 0.000

Low

80.00

Averages

87.50

High

90.00

Cantor Fitzgerald

Overweight

downgrade

$87 -> $85

2026-01-05

New

Reason

Cantor Fitzgerald

Price Target

$87 -> $85

2026-01-05

New

downgrade

Overweight

Reason

Cantor Fitzgerald lowered the firm's price target on National Health Investors to $85 from $87 and keeps an Overweight rating on the shares. U.S. equity REITs returned 2.9% in 2025, lagging the S&P 500, but 2026 may offer optimism with a potentially more supportive macro environment and an accelerating M&A theme, the analyst tells investors in a research note. Stable supply and demand fundamentals, balance sheet strength, and a well-covered, growing 4% dividend yield make the sector attractive despite past underperformance, Cantor adds.

Truist

Buy

maintain

$81 -> $83

2025-12-16

Reason

Truist

Price Target

$81 -> $83

2025-12-16

maintain

Buy

Reason

Truist raised the firm's price target on National Health Investors to $83 from $81 and keeps a Buy rating on the shares. The company's Q3 same-store senior housing operating portfolio performance was not as strong as we expected, but fundamentals remain firmly at the company's back and there appears to be a strong pipeline of accretive investment opportunities, the analyst tells investors in a research note.

KeyBanc

Overweight

maintain

$80 -> $88

2025-12-04

Reason

KeyBanc

Price Target

$80 -> $88

2025-12-04

maintain

Overweight

Reason

KeyBanc raised the firm's price target on National Health Investors to $88 from $80 and keeps an Overweight rating on the shares. The firm views National Health Investors as an attractive way to gain exposure to a Healthcare REIT with an attractive cost of capital and below average leverage that can capitalize on the current investment landscape and drive upside to 2026 and 2027 NFFO estimates. Importantly, the investments should continue to grow the company's Senior Housing Operating Portfolio exposure and potentially enhance its internal growth profile, over time. Moreover, potential positive catalysts from available market rent resets and lease expirations in early-to-mid 2026 could drive additional upside to NFFO estimates, KeyBanc adds.

Wells Fargo

John Kilichowski

Equal Weight

maintain

$80 -> $85

2025-11-25

Reason

Wells Fargo

John Kilichowski

Price Target

$80 -> $85

2025-11-25

maintain

Equal Weight

Reason

Wells Fargo analyst John Kilichowski raised the firm's price target on National Health Investors to $85 from $80 and keeps an Equal Weight rating on the shares. The firm says that despite a few high-profile exceptions, most REITs delivered Q3 2025 earnings and outlooks reflecting healthy operating conditions despite macro and labor market concerns.

BofA

Buy

maintain

$88 -> $90

2025-11-17

Reason

BofA

Price Target

$88 -> $90

2025-11-17

maintain

Buy

Reason

BofA raised the firm's price target on National Health Investors to $90 from $88 and keeps a Buy rating on the shares. While stock performance did not reflect it, Q3 earnings season was "strong" for U.S. REITs as 69% of REITs beat the Street, the analyst tells investors in a note on the group.

BofA

Buy

maintain

$87 -> $88

2025-10-17

Reason

BofA

Price Target

$87 -> $88

2025-10-17

maintain

Buy

Reason

BofA raised the firm's price target on National Health Investors (NHI) to $88 from $87 and keeps a Buy rating on the shares. A "silver tsunami' in the U.S. is expected to to drive big gains for the major players in the senior housing business as Boomers age into senior living, says the analyst, who forecasts that margins for the five SHOP REITs- Welltower (WELL), Ventas (VTR), Sabra (SBRA), American Healthcare REIT (AHR) and National Health - will expand ahead of Street estimates in 2026.

Valuation Metrics

The current forward P/E ratio for National Health Investors Inc (NHI.N) is 23.07, compared to its 5-year average forward P/E of 21.06. For a more detailed relative valuation and DCF analysis to assess National Health Investors Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

5Y Average PE

21.06

Current PE

23.07

Overvalued PE

24.14

Undervalued PE

17.98

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

15.30

Current EV/EBITDA

15.17

Overvalued EV/EBITDA

16.62

Undervalued EV/EBITDA

13.97

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

8.90

Current PS

9.45

Overvalued PS

10.12

Undervalued PS

7.68

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

NHI News & Events

Events Timeline

No data

News

4.0

2025-11-21NASDAQ.COM

National Health Investors (NHI) Pursues Acquisition: Reasons for the Upgrade

6.5

2025-10-20CNBC

The S&P 500 Becomes an AI-Focused Index: Stocks to Diversify Your Portfolio Against Potential Setbacks

2.0

2025-10-13NASDAQ.COM

National Health Investors (NHI) Stock Falls Below 200-Day Moving Average

People Also Watch

Frequently Asked Questions

What is National Health Investors Inc (NHI) stock price today?

The current price of NHI is 77.64 USD — it has decreased -0.47 % in the last trading day.

What is National Health Investors Inc (NHI)'s business?

National Health Investors, Inc. is a real estate investment trust. The Company specializes in sales, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. It operates through two segments: Real Estate Investments and Senior Housing Operating Portfolio (SHOP). The Real Estate Investments segment consists of real estate investments, leases, and mortgage and other notes receivables in independent living facilities, assisted living facilities, entrance-fee communities, senior living campuses, skilled nursing facilities and a hospital. It has approximately 193 healthcare real estate properties located in 33 states and leased primarily pursuant to triple-net leases to 27 tenants. The SHOP segment is comprised of two ventures that own the operations of independent living facilities. This segment has over 15 properties located in eight states with a combined 1,732 units.

What is the price predicton of NHI Stock?

What is National Health Investors Inc (NHI)'s revenue for the last quarter?

National Health Investors Inc revenue for the last quarter amounts to 89.85M USD, increased 8.32 % YoY.

What is National Health Investors Inc (NHI)'s earnings per share (EPS) for the last quarter?

National Health Investors Inc. EPS for the last quarter amounts to 0.69 USD, increased 6.15 % YoY.

What changes have occurred in the market's expectations for National Health Investors Inc (NHI)'s fundamentals?

How many employees does National Health Investors Inc (NHI). have?

National Health Investors Inc (NHI) has 25 emplpoyees as of January 08 2026.

What is National Health Investors Inc (NHI) market cap?

Today NHI has the market capitalization of 3.70B USD.